Published October, 2012
By H.M. Pinedo, H.D. Suit, J. Verweij and Jaap Verweij
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Treatment and Research
Rating:
Availability: Available
By H.M. Pinedo, H.D. Suit, J. Verweij and Jaap Verweij
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Treatment and Research
Rating:
Availability: Available
Sophisticated histopathology techniques and growing consensus on grading systems have further increased the importance of the histopathologist in providing estimates of the prognosis of the patient as well as providing data for the planning of treatment strategy.
Paperback / softback
€219.59
Published October, 2012
By Richard K. Burt and Mary M. Brush
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Treatment and Research
Rating:
Availability: Available
By Richard K. Burt and Mary M. Brush
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Treatment and Research
Rating:
Availability: Available
The field of hematopoietic stem cell transplantation is rapidly evolving. Realization that hematopoietic stem cells give rise to the immune compartment has resulted in clinical trials of hematopoietic stem cell transplantation for patients with autoimmune diseases.
Paperback / softback
€268.39
Published October, 2012
By Raymond C. Bergan
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Treatment and Research
Rating:
Availability: Available
By Raymond C. Bergan
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Treatment and Research
Rating:
Availability: Available
Paperback / softback
€134.19
Published October, 2012
By David S. Ettinger
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Treatment and Research
Rating:
Availability: Available
By David S. Ettinger
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Treatment and Research
Rating:
Availability: Available
In the United States alone, the incidence of new cases of thoracic neoplasms is over 180,000. It is the leading cause of cancer death in both men and women, accounting for 28% of all cancer deaths in the United States.
Paperback / softback
€158.59
Published October, 2012
By Hagop Kantarjian and Emil J. Freireich
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Treatment and Research
Rating:
Availability: Available
By Hagop Kantarjian and Emil J. Freireich
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Treatment and Research
Rating:
Availability: Available
As a result, this multi-authored volume, devoted to advances which have occurred over the last seven years, provides the reader with an important new understanding of leukemia, but perhaps even more important, predicts analogous, new developments in the other malignant diagnoses.
Paperback / softback
€134.19
Published October, 2012
By David Murray and Borje Andersson
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Treatment and Research
Rating:
Availability: Available
By David Murray and Borje Andersson
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Treatment and Research
Rating:
Availability: Available
Over the last several decades, the introduction of new chemotherapeutic drugs and drug combinations has resulted in increased long term remission rates in several important tumor types.
Paperback / softback
€134.19
Published October, 2012
By Azra Raza and Suneel D. Mundle
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Treatment and Research
Rating:
Availability: Available
By Azra Raza and Suneel D. Mundle
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Treatment and Research
Rating:
Availability: Available
Attempts to harness the inherent complexity of MDS by devising `classifications' which group the various syndromes as one disease is as misguided as saying that a pneumonia is not infectious because it did not respond to antibiotics.
Paperback / softback
€134.19
Published October, 2012
By Christopher Benz and E.T. Liu
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Treatment and Research
Rating:
Availability: Available
By Christopher Benz and E.T. Liu
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Treatment and Research
Rating:
Availability: Available
The first edition of Oncogenes (1989) focused on several of the better known transforming mechanisms and surveyed a spectrum of solid tumors and hematologic malignancies.
Paperback / softback
€304.99
Published October, 2012
By Paul H. Sugarbaker
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Treatment and Research
Rating:
Availability: Available
By Paul H. Sugarbaker
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Treatment and Research
Rating:
Availability: Available
Gastric cancer has been one of the great malignant scourges affecting man kind for as long as medical records have been kept. Some changes have resulted from better understanding of the disease, early detec tion, and better management techniques with applied clinical research, but the reasons for other changes are poorly understood.
Paperback / softback
€268.39
Published October, 2012
By Herbert Lepor and Russell K. Lawson
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Treatment and Research
Rating:
Availability: Available
By Herbert Lepor and Russell K. Lawson
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Treatment and Research
Rating:
Availability: Available
It is an attempt to establish a critical mass of oncology literature covering virtually all oncology topics, revised frequently to keep the coverage up to date, and easily available on a single library shelf or by a single personal subscription.
Paperback / softback
€134.19